http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4335128-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 |
| filingDate | 1980-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1982-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52e669087a6d80faea4e5f8795171ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb4db0bbbaac0c6b3933e503f0c073b |
| publicationDate | 1982-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4335128-A |
| titleOfInvention | Process for the treatment of patients suffering from drepanocytosis |
| abstract | This invention relates to a process for the treatment of patients suffering from drepanocytosis, comprising administering to said patients a therapeutically effective dosage of a pyridine derivative having the formula: <IMAGE> (I) in which X is oxygen or sulfur; R is oxygen or a phenyl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, nitro, amino, sulfonylamino, aryl, carboxy, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; styryl, naphthyl, thienyl or benzhydryl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, aryl, nitro, amino, sulfonylamino, carboxyl, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; benzoyl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, nitro, amino or sulfonylamino group; R1 and R2 each represent at least one atom or group selected from hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy, nitro or amino; R3 is hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy, nitro or amino; and n is zero or an integer from 1 to 15; and R3 may have a different meaning in each CHR3 group when n is greater than 1; or a pharmaceutically acceptable acid addition salt or quaternary ammonium derivative of said compound. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5109008-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5998433-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6576641-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0043397-A1 |
| priorityDate | 1977-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.